
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Med.
Sec. Gastroenterology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1533544
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
This study aimed to systematically analyze the trends in gastric cancer burden in China and globally from 1990 to 2021 using data from the Global Burden of Disease (GBD) database, and to forecast future trends from 2022 to 2036. The findings provide a scientific basis for developing targeted gastric cancer prevention and control policies.Methods Age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) for gastric cancer from 1990 to 2021 were extracted from the GBD database. These data were complemented by GLOBOCAN 2022 statistics to analyze the spatiotemporal characteristics of gastric cancer burden across time, sex, and regions. An autoregressive integrated moving average (ARIMA) model was employed to predict trends from 2022 to 2036.
Keywords: gastric cancer, disease burden, Incidence, Prevalence, socio-demographic index
Received: 24 Nov 2024; Accepted: 25 Feb 2025.
Copyright: © 2025 Yin and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yulai Yin, Hebei Medical University, Shijiazhuang, China
Xiaoyu Zhang, Cangzhou Central Hospital, Cangzhou, 061001, Hebei, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.